The JAK/STAT plays critical roles in regulating cytokines including IL-6, IL-12, IL-23, IFN-γ, and GM-CSF implicated in MS; consequently, there has been interest in targeting the JAK/STAT pathway as a treatment for MS or EAE. This evidence concerns the gene CSF2 and myeloid sarcoma.